Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Real Estate Investment Trusts – Zacks Analyst Interviews

Zacks Market Commentaries (October 23rd, 2009) Writes:
Amid positive signals emanating from the uptick in housing prices and an improving outlook for consumer spending, the housing sector is gradually stabilizing. Both new and existing home sales have increased during the last four consecutive months and are now 32% and 17% above their recent lows, respectively. Single-family housing starts have also risen 37% from their low point, and inventories of homes-for-sale have fallen sharply.

Equity REITs rebounded nicely in the third quarter, recording total returns of 33% (total return FTSE NAREIT Index) vs. a 15% gain each for the S&P and the Dow. The strong third quarter returns marked the second consecutive record-setting performance of equity REITs after a dismal performance in the first quarter of 2009.

In what has been a volatile year, equity REITs gained approximately 29% (total return FTSE NAREIT Index) in the second quarter after falling 32% in the first quarter. So far in October, equity

...

Real Estate Investment Trusts – Industry Outlook

Zacks Market Commentaries (October 23rd, 2009) Writes:
Amid positive signals emanating from the uptick in housing prices and an improving outlook for consumer spending, the housing sector is gradually stabilizing. Both new and existing home sales have increased during the last four consecutive months and are now 32% and 17% above their recent lows, respectively. Single-family housing starts have also risen 37% from their low point, and inventories of homes-for-sale have fallen sharply.

Equity REITs rebounded nicely in the third quarter, recording total returns of 33% (total return FTSE NAREIT Index) vs. a 15% gain each for the S&P and the Dow. The strong third quarter returns marked the second consecutive record-setting performance of equity REITs after a dismal performance in the first quarter of 2009.

In what has been a volatile year, equity REITs gained approximately 29% (total return FTSE NAREIT Index) in the second quarter after falling 32% in the first quarter. So far in October, equity

...

Real Estate Investment Trusts – Industry Outlook

Zacks Market Commentaries (October 22nd, 2009) Writes:
Amid positive signals emanating from the uptick in housing prices and an improving outlook for consumer spending, the housing sector is gradually stabilizing. Both new and existing home sales have increased during the last four consecutive months and are now 32% and 17% above their recent lows, respectively. Single-family housing starts have also risen 37% from their low point, and inventories of homes-for-sale have fallen sharply. Equity REITs rebounded nicely in the third quarter, recording total returns of 33% (total return FTSE NAREIT Index) vs. a 15% gain each for the S&P and the Dow. The strong third quarter returns marked the second consecutive record-setting performance of equity REITs after a dismal performance in the first quarter of 2009. In what has been a volatile year, equity REITs gained approximately 29% (total return FTSE NAREIT Index) in the second quarter after falling 32% in the first quarter. ...

DrStockPick.com Stock Report! 10/15/09, CVAT, HME, AMSWA, CVG, TECD, PFE, WYE

Dr. Stock Pick (October 15th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

Thursday October 15, 2009

DrStockPick.com Stock Report!

**************************************************************

Cavitation Technologies, Inc. (CTI) (OTC Bulletin Board: CVAT) has signed Miura Engineering Co., Ltd. Tokyo, Japan (www.miura21.co.jp) as its new agent to serve markets in Japan for CTI’s Nano-Cavitation Process Systems. Miura is a leading Engineering Company specialized in Edible Oil Processing Plants in the Far East.

Home Properties (NYSE: HME) is starting to make the conversion from old, outdated, incandescent light bulbs to energy-efficient, longer lasting compact fluorescent light bulbs (CFLs). The change began in

...

DrStockPick.com Stock Report! 10/12/09, APD, SNWL, SFLY, NKE, PRVT, NXTH

Dr. Stock Pick (October 12th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

Monday October 12, 2009

DrStockPick.com Stock Report!

**************************************************************

Air Products (NYSE: APD) will feature its broad line of solutions for water and wastewater treatment, now marketed globally under the Halia(TM) brand name, at WEFTEC 2009 in Orlando, Fla., from October 10-14. The company’s offerings include pure oxygen aeration systems for wastewater treatment, as well as ozone advanced oxidation systems for drinking water and water reuse applications.

SonicWALL, Inc. (Nasdaq: SNWL), a leading secure network infrastructure company, today announced that its Unified Threat Management (UTM) and IPSec

...
Tags for this Post:
adult entertainment products, aeration, Air Products, American Lung Association, Avaya;, beverage products, Bluebird Films, business communications applications;, ceo, company executive, Company’s Medical Advisory Board, content distribution network, Diabetes, Dr Stock Pick, Florida, food, Internet-based social expression, Investing Lessons, IPSec VPN solutions, Jack Boys, James R. Gavin III, key Internet protocol, Media Channels, Michael Spillane, Nike Inc, NXT Nutritionals Holdings Inc.;, olympics, Orlando, oxidation systems, Private Media Group Inc., pure oxygen aeration systems, Shutterfly Inc;, SonicWall Inc;, Special Olympics and World Wildlife Fund, Stocks to Watch, SUSTA Natural Sweetener, SUSTA(TM) Natural Sweetener, telephony solutions, VPN, wastewater treatment, water reuse applications, Worldwide Leader

Taubman Writes Down Asset Values – Analyst Blog

Zacks Market Commentaries (September 23rd, 2009) Writes:
Taubman Centers Inc. (TCO) recently said it would record impairment charges of $161 million to $169 million in the third quarter. The real estate investment trust is writing down book values of its The Pier Shops at Caesars asset in New Jersey and Regency Square in Virginia to fair values due to the continued economic downturn.

The Pier Shops at Caesars is a 282,000 square feet shopping center in which Taubman owns a 77.5% stake. The company considers net operating income from the property to be insufficient to repay its $135 million non-recourse mortgage debt. Thus, it will write down book value of the asset by $106 million to $111 million, out of which Taubman has a share of about $100 million to $105 million.

Regency Square is an 820,000 square feet shopping center housing leading fashion retailers like Macy’s Inc. (M), J. C. Penney Co. Inc.

...

Taking Cancer Treatment to a New Level (OTC:PVCT)

Michael Vlaicu (September 16th, 2009) Writes:

Provectus Pharmaceuticals, Inc.

(Public, OTC:PVCT)

StocksHaven Investments profiles one of the most exciting up-and-coming anti-cancer companies in the industry, Provectus Pharmaceuticals (OTC:PVCT). They have one of the deepest pipelines of any small cap biotech, focusing on treatments for: Melanoma, Psoriasis, Atopic Dermatitis, Breast Cancer, and Liver Metastasis. With three drugs nearly ready to enter Phase III, including one nearly entering Phase II for Breast Cancer, one of the largest target markets worldwide and seeking “compassionate use” in Australia and USA, look for Provectus to make a splash within the next couple of months.

They are developing and testing one of the most exciting anti- cancer compounds. It has been demonstrating significant effectiveness against Melanoma in Phase 2 clinical trials and it offers promising treatment for breast, liver and other solid tumor based metastatic cancers. The compound developed by Provectus, known as PV-10, is a

...
Tags for this Post:
actress, American Society of Clinical Oncology;, Analyst, and plans to sell, and plans to sell products, Atopic Dermatitis, Australia, Biopharmaceutical, Blue channel, Bob Marley;, Breast Cancer, cancer, Cancer of the skin, Cancers, cent;, Cybill Shepherd, device systems, Elizabeth Taylor, Eva Cassidy, Fda, FDA protocol, Florida, Healthcare Industry, invasive products, John F. Thompson, john mccain, lead investigator, Liver Cancer, malignant melanomas, Melanoma, Michael Vlaicu;, New York City, Orlando, owned subsidiaries, prescription drug products, Professor, Provectus Biotech Inc., Provectus Devicetech Inc., Provectus Imaging Inc. IP, Provectus Pharmaceuticals Inc., Provectus Pharmatech Inc., psoriasis, PURE;, PV-10, Ronald Reagan, Sam Donaldson, skin cancer, skin cancers, Stocks to Watch, surgery, thin tumours, treatment for melanoma, treatment of psoriasis, tumor, tumors, United States, USD, World Health Organization, Xantech Pharmaceuticals Inc., Yahoo

Atheros Ups Guidance, Buys ITLN – Analyst Blog

Zacks Market Commentaries (September 11th, 2009) Writes:
Atheros Communications Inc. (ATHR) recently updated its guidance for the third quarter. The company now expects revenues between $145 million and $150 million, up 29%–30% sequentially and up from the earlier projection of revenues between $129.0 million and $134.6 million. EPS (excluding one-time charges) is projected between 35 cents and 39 cents compared to the previous guidance between 29 cents and 31 cents. California-based Atheros Communications is a leader in the designing of chipsets used in WLAN devices. Atheros also announced that it will acquire Intellon Corporation (ITLN) in a stock and cash transaction valued at approximately $244 million or $181 million net of cash and equivalents. Atheros expects to close this transaction by the fourth quarter of 2009. Headquartered in Orlando, FL, Intellon Corporation designs, develops and markets integrated circuits (ICs) on a global basis for powerline communications or high-speed communications over ...

The Top 10 Reasons Why the China Sell Off Will Continue

Investment U (September 1st, 2009) Writes:

The Top 10 Reasons Why the China Sell Off Will Continue

by Louis Basenese, Advisory Panelist

How much are you willing to pay for good advice? And by “good,” I mean profitable.

A couple of hundred bucks? A couple of thousand?

Before you answer, consider this: Two weeks ago, I alerted members of The Oxford Club to the precarious position of Chinese equities. As I put it, “China could be on a crash course with a correction.”

A contrarian stance, no doubt. But vindication came quickly.

The following Monday, Chinese stocks (represented by the Shanghai Composite Index) suffered a 5.8% drop – the worst single-day decline of the year. Two days later, they got dented by another 4.3%.

Unabashed China bulls will point out that the Shanghai index promptly recovered. But then this week hit…

Rally Rebuffed: Chinese Stocks Take Another Tumble

On Monday, the

...

Why Housing Prices Will Keep Dropping in Value

Investment U (August 28th, 2009) Writes:

Why Housing Prices Will Keep Dropping in Value

by Alexander Green, Advisory Panelist

Good news has been swirling around the housing market lately.

The Commerce Department reported on Wednesday that sales of new U.S. homes surged 9.6% in July.

A week before, the National Association of Realtors reported that previously-owned home sales in July jumped at the fastest rate in 10 years.

Realtors are now reminding us that sales have risen for four consecutive months. Thanks to low interest rates and government incentives, they tell us, housing prices will soon be heading back up.

Don’t bet on it…

I was in real estate for years. Asking my colleagues whether prices were likely to head higher was like asking the Army Corp of Engineers whether a river needed a bridge.

The answer was a foregone conclusion.

In many ways, this is understandable. Real estate agents

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.